ConductScience.org, home

Paper34192529

SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.

Amanat F and 22 others. Cell, 2021. Cited by 259 papers, by iCite.

Cite this record

ConductScience Library. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Papers, record 34192529. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34192529

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.
PubMed
Journal
Cell
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
259
iCite
Relative citation ratio, by iCite
10.6
iCite
Revised in PubMed
2026-05-18
PubMed

Authors23

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Amanat FFatima
2Thapa MMahima
3Lei TTinting
4Ahmed SMSShaza M Sayed
5Adelsberg DCDaniel C
6Carreño JMJuan Manuel
7Strohmeier SShirin
8Schmitz AJAaron J
9Zafar SSarah
10Zhou JQJulian Q
11Rijnink WWillemijn
12Alshammary HHala
13Borcherding NNicholas
14Reiche AGAna Gonzalez
15Srivastava KKomal
16Sordillo EMEmilia Mia
17van Bakel HHarm
18Personalized Virology InitiativeGroup
19Turner JSJackson S
20Bajic GGoran

Source PubMed

See all 23 authorsDownload CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, ViralMajor topic
COVID-19 VaccinesMajor topic
RNA, MessengerMajor topic
SARS-CoV-2Major topic
Spike Glycoprotein, CoronavirusMajor topic
VaccinationMajor topic
Amino Acid Substitution
Angiotensin-Converting Enzyme 2
Antibodies, Monoclonal
Antibodies, Neutralizing
Antibody Formation
Binding, Competitive
Humans
Immunoglobulin G
Mutation
Protein Domains
Somatic Hypermutation, Immunoglobulin

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U01 AI141990NIAID NIH HHSUnited StatesU01AI141990PubMed and NIHNIH RePORTER
S10 OD026880NIH HHSUnited StatesS10OD026880PubMedNIH RePORTER
75N93019C00051NIAID NIH HHSUnited StatesPubMedPubMed
U01 AI150747NIAID NIH HHSUnited StatesU01AI150747PubMed and NIHNIH RePORTER
HHSN272201400008CNIAID NIH HHSUnited StatesPubMedPubMed
T32 CA009547NCI NIH HHSUnited StatesT32CA009547PubMed and NIHNIH RePORTER
HHSN272201400006CNIAID NIH HHSUnited StatesPubMedPubMed

Download CSV of grants

References69

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132425270Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells.Cell2020https://conductscience.org/library/papers/32425270PubMed
233780970Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.Nature2021https://conductscience.org/library/papers/33780970PubMed
324300384Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system.J Vis Exp2013https://conductscience.org/library/papers/24300384PubMed
432571838A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.Science2020https://conductscience.org/library/papers/32571838PubMed
524412922Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo.Nat Med2014https://conductscience.org/library/papers/24412922PubMed
632789006scRepertoire: An R-based toolkit for single-cell immune receptor analysis.F1000Res2020https://conductscience.org/library/papers/32789006PubMed
732094589Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.Nat Microbiol2020https://conductscience.org/library/papers/32094589PubMed
819247287Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen.Nat Protoc2009https://conductscience.org/library/papers/19247287PubMed
915608191IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.Nucleic Acids Res2005https://conductscience.org/library/papers/15608191PubMed
1033761326N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.Cell2021https://conductscience.org/library/papers/33761326PubMed
1132555388Convergent antibody responses to SARS-CoV-2 in convalescent individuals.Nature2020https://conductscience.org/library/papers/32555388PubMed
1232075877Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.Science2020https://conductscience.org/library/papers/32075877PubMed
1333112236Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.Elife2020https://conductscience.org/library/papers/33112236PubMed
1428807998Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28807998PubMed
1532585083An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening.Curr Protoc Microbiol2020https://conductscience.org/library/papers/32585083PubMed
1633232870Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate.EBioMedicine2020https://conductscience.org/library/papers/33232870PubMed
1733654292SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.Nat Med2021https://conductscience.org/library/papers/33654292PubMed
1818449194Rapid cloning of high-affinity human monoclonal antibodies against influenza virus.Nature2008https://conductscience.org/library/papers/18449194PubMed
1932398876A serological assay to detect SARS-CoV-2 seroconversion in humans.Nat Med2020https://conductscience.org/library/papers/32398876PubMed
2030940710Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus.mBio2019https://conductscience.org/library/papers/30940710PubMed

See all 69 referencesDownload CSV of references

Cited by210

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 259 citations.

PMIDTitleJournalYearIn PapersSource
42911442Broad-spectrum aptamers: recent advances in selection strategies, structural mechanisms, and biosensing applications.Mikrochim Acta2026https://conductscience.org/library/papers/42911442PubMed
42649161Temperature-dependent replication and sensitivity to innate immunity of human coronavirus HKU1.Nat Commun2026https://conductscience.org/library/papers/42649161PubMed
42571698Functional and structural basis of Omicron BA.3.2.1 spike.Cell Rep2026https://conductscience.org/library/papers/42571698PubMed
42465777Shared germline-biased plasmablast clonotypes shape early neutralizing antibody responses during acute Chikungunya virus infection.Front Immunol2026https://conductscience.org/library/papers/42465777PubMed
42364994Intranasal boosting induces variant-specific responses in SARS-CoV-2 vaccine-imprinted mice.Nat Commun2026https://conductscience.org/library/papers/42364994PubMed
42240400Cell-Mediated Immunity of mRNA-1283 Vaccine Encoding SARS-CoV-2 Spike Receptor-Binding and N-Terminal Domains in Preclinical and Clinical Studies.J Infect Dis2026https://conductscience.org/library/papers/42240400PubMed
42034652Prefusion-stabilized SARS-CoV-2 spike reshapes antigenic hierarchy and antibody targeting against conserved and occluded epitopes.NPJ Vaccines2026https://conductscience.org/library/papers/42034652PubMed
42030951Dissecting serum polyclonal antibody escape to SARS-CoV-2 variants by deep mutational learning.Cell Rep Methods2026https://conductscience.org/library/papers/42030951PubMed
42022217Building better antibody responses: The interplay of infection, vaccination, and immune imprinting.PNAS Nexus2026https://conductscience.org/library/papers/42022217PubMed
41882251Design and immunogenicity evaluation of pan-recombinant vaccines based on the consensus sequence of severe acute respiratory syndrome coronavirus-2 spike protein.Sci Rep2026https://conductscience.org/library/papers/41882251PubMed
41818265Determinants of natural killer cell-mediated antibody dependent cellular cytotoxicity in SARS-CoV-2 antibodies.PLoS Pathog2026https://conductscience.org/library/papers/41818265PubMed
41756886The buried S2 apex of SARS-CoV-2 spike elicits an immunodominant germline-restricted public antibody response.bioRxiv2026https://conductscience.org/library/papers/41756886PubMed
41666181A SARS-CoV-2 variant-induced NTD-targeting antibody enhances viral infection via a distinctive binding mode.PLoS Pathog2026https://conductscience.org/library/papers/41666181PubMed
41623474Neutralization and ADCC reveal divergent spike-subdomain targeting across SARS-CoV-2 vaccine platforms in an African cohort.iScience2026https://conductscience.org/library/papers/41623474PubMed
41583464Viral glycoprotein-mediated entry and antibody-mediated immunity in HIV-1 and SARS-CoV-2 infection.Front Immunol2025https://conductscience.org/library/papers/41583464PubMed
41387968Characterization and immunogenicity of nanoparticle vaccines based on Clade 2 and Clade 3 sarbecovirus S2 proteins.NPJ Vaccines2025https://conductscience.org/library/papers/41387968PubMed
41376258SARS-CoV-2 Infection With Alpha B.1.1.7 Virus Induced Higher Antibody Responses Than Earlier Non-VOC Variants During the First Waves of the COVID-19 Pandemic in Norway.APMIS2025https://conductscience.org/library/papers/41376258PubMed
41295541Current Status and Challenges of Vaccine Development for Seasonal Human Coronaviruses.Vaccines (Basel)2025https://conductscience.org/library/papers/41295541PubMed
41234640SARS-CoV-2 mRNA vaccine candidate encoding RBD chimera of Delta and Omicron variants: immunogenic potential and validation.Iran J Microbiol2025https://conductscience.org/library/papers/41234640PubMed
41103414Impact of an aerosolized or intramuscular adenovirus type 5-vectored COVID-19 vaccine on Fc-mediated immune effector functions in a hybrid immunity population.Front Immunol2025https://conductscience.org/library/papers/41103414PubMed

See all 210 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34192529

GET https://conductscience.org/api/papers/v1/34192529/authors?page=2